Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

37
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
37
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

50
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

55
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
55
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

69
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
69
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

42
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From competence to entrustment: strengthening clinical autonomy within the ESICM educational framework.

Intensive care medicine·2026
Same author

Marine Lipids and Alzheimer's Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects.

Marine drugs·2026
Same author

The challenge of sepsis in older adults in the Emergency Department and intensive care units.

Critical care science·2026
Same author

Plasma Albumin Changes During Admission for Bloodstream Infection as Prognostic Predictors After Discharge-A Population-Based Cohort Study.

Journal of clinical medicine·2026
Same author

The environmental cost of learning: CO<sub>2</sub> emission comparisons of virtual reality, online, and alternative distance education.

Intensive care medicine·2026
Same author

Impact of appropriate antimicrobial therapy on patient outcomes and antimicrobial use: a sub analysis of the DIANA Study Dataset.

Intensive care medicine·2026

Related Experiment Video

Updated: Oct 30, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.1K

Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.

Pedro Póvoa1,2,3, Patrícia Moniz1, João Gonçalves Pereira2,4

  • 1Polyvalent Intensive Care Unit, Sao Francisco Xavier Hospital, CHLO, 1449-005 Lisbon, Portugal.

Microorganisms
|July 2, 2021
PubMed
Summary

Optimizing antimicrobial dosing in critically ill patients is crucial for effective sepsis treatment. This review examines challenges and tools for individualizing antimicrobial therapy to maximize effectiveness and minimize resistance.

Keywords:
antibioticspharmacokineticssepsis

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.8K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.0K

Related Experiment Videos

Last Updated: Oct 30, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.1K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.8K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.0K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Early empiric antimicrobial therapy is vital for sepsis and septic shock management.
  • Effective treatment requires appropriate antimicrobial choice, dose, route, and administration.
  • Critically ill patients exhibit altered pharmacokinetics, complicating antimicrobial dosing.

Purpose of the Study:

  • To review literature on challenges and tools for optimizing antimicrobial dosing in critically ill patients.
  • To assess strategies for individualizing antimicrobial therapy to maximize drug exposure and effectiveness.
  • To address the impact of pharmacokinetics and pharmacodynamics on antimicrobial efficacy.

Main Methods:

  • Literature review of pharmacokinetic and pharmacodynamic principles.
  • Analysis of antimicrobial dosing strategies in critically ill populations.
  • Evaluation of tools for therapeutic drug monitoring and resistance management.

Main Results:

  • Antimicrobial dosing in critically ill patients is complex due to variable pharmacokinetics and clinical status.
  • Optimizing drug schedules is challenging due to changing patient conditions and drug clearance.
  • Rising antimicrobial resistance and limited new agents exacerbate treatment difficulties.

Conclusions:

  • Individualized antimicrobial dosing is essential for improving outcomes in critically ill patients.
  • Further research and implementation of advanced dosing strategies are needed.
  • Balancing efficacy, toxicity, and resistance requires a multifaceted approach to antimicrobial therapy.